| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |